查詢結果分析
來源資料
相關文獻
- Experiences with High-Frequency Oscillatory Ventilation in Premature Infants with Respiratory Distress Syndrome
- 早產兒呼吸窘迫症候群之預防及治療
- 以表面張力素治療早產兒呼吸窘迫症候群的概況
- 慢性肺部疾病
- 早產兒呼吸窘迫症候群之預防與治療
- Persistent Pulmonary Hypertension in Preterm Infants with RDS
- 擺位姿勢對嬰幼兒肺功能的影響
- 早產兒呼吸窘迫症候群處理之最新進展
- 早產兒之呼吸窘迫症候群
- Bovine and Synthetic Surfactants for Treatment of Respiratory Distress Syndrome in Premature Infants: A Multicentre Trial
頁籤選單縮合
題 名 | Experiences with High-Frequency Oscillatory Ventilation in Premature Infants with Respiratory Distress Syndrome=使用高頻振盪式呼吸器治療早產兒呼吸窘迫症候群之初期臨床經驗 |
---|---|
作 者 | 鄭玫枝; 宋文舉; 陳淑貞; 彭致勝; 黃碧桃; | 書刊名 | 中華醫學雜誌 |
卷 期 | 61:9 1998.09[民87.09] |
頁 次 | 頁531-537 |
分類號 | 417.5171 |
關鍵詞 | 高頻振盪式呼吸器; 早產兒; 呼吸窘迫症候群; High-frequency oscillatory ventilation; Premature infants; Respiratory distress syndrome; |
語 文 | 英文(English) |
中文摘要 | 本文報告2例急性出血之後天性A型血友病病例。第1例為一27歲女性,她於 自然產第二胎後第6天,會陰切開之傷囗處發生自發性出血,雖絰兩次縫合及于宮內膜括除 術,仍流血不止;後又因子宮破裂導致腹腔內出血而接受緊急剖腹手術止血。手術後傷囗又 持續出血,最後發現其體內第VⅢ凝血因子抗體濃度為每毫升19BU。雖經輸注第Ⅸ凝血因子 濃縮液和免疫抑制劑,病患仍不幸死亡。第2例為一22歲男性患者,其於住院前1個月開 始出現自發性及復發性的右大腿內側出血,實驗室檢查慬發現部分凝血酵素原時間延長,最 後亦證實其血中有第VⅢ凝血因子抗體存在,濃度為每毫升5.9BU。此病人經施予血漿交換 術並投予囗服免疫抑制劑及皮質類固醇後成功地治癒。 肵f,到出生後36週大時只有1位仍有中度慢性肺病。1位早產兒死於非肺部原因的敗血 症;總存活率為90﹪。在治療過程中無新的氣漏症候群(air-leak syndrome)產生,其它 常見的早產兒併發症發生率也極少。 結論 使用高頻振盪式呼吸器治療早產兒的呼吸窘迫症候群是有效和安全的,尤其能降低慢 性肺病與氣漏症候群的發生率。 |
英文摘要 | Two patients who presented with active bleeding and were diagnosed with acquired hemophilia A (AHA) are reported herein. One was a 27-year-old woman who experienced spontaneous oozing from an episiotomy wound six days after her second normal delivery. Bleeding became progressively worse, despite treatment with primary sutures and curettage of the uterus at a local hospital. She underwent emergency exploratory laparotomy because of intra-abdominal bleeding, during which perforations of the uterus were discovered. Unremitting bleeding from the surgical wound occurred after surgery. The patient was finally diagnosed with AHA when Factor VIII (FVIII) inhibitor (titer, 19 Bethesda units (BU)/ml) was detected in her plasma. She died of refractory hemorrhaging, despite intensive treatment with Factor IX concentrate infusion and cyclophosphamide therapy. The second patient was a 22- year-old man who sustained spontaneous and recurrent intramuscular hemorrhage in the right thigh for one month. Laboratory studies including complete blood count, biochemical evaluation, coagulation screening and immunologic assays were all within normal limits, except for a prolonged activated partial thromboplastin time. Idiopathic AHA was diagnosed after the detection of plasma FVⅢ inhibitor with a concentration of 5.9 BU/ml. The patient's coagulopathy was successfully managed with plasma exchange and subsequent treatment with oral prednisolone and cyclophosphamide. |
本系統中英文摘要資訊取自各篇刊載內容。